Worldwide prevalence of hypertension: A systematic review

Journal of Hypertension

Volumn 22, Issue 1, 2004, Pages 11-19

  Kearney, Patricia M ^a   Whelton, Megan ^a   Reynolds, Kristi ^a   Whelton, Paul K ^a,b   He, Jiang ^a,b  

^a TULANE UNIVERSITY   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blood pressure; Cross sectional studies; Detection and control of hypertension; Population; Prevalence

Indexed keywords

AWARENESS; CLINICAL PROTOCOL; DATA ANALYSIS; DATA BASE; DEMOGRAPHY; HUMAN; INFORMATION PROCESSING; INFORMATION RETRIEVAL; MEDICAL LITERATURE; MEDLINE; POPULATION RESEARCH; PRIORITY JOURNAL; PUBLICATION; REVIEW; SAMPLE SIZE; SYSTEMATIC REVIEW; SYSTOLIC HYPERTENSION;

EID: 1442299103     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200401000-00003     Document Type: Review

References (68)

1. He J, Whelton PK. Epidemiology and prevention of hypertension. Med Clin North Am 1997; 81:1077-1097.
2. Whelton PK. Epidemiology of hypertension. Lancet 1994; 344:101-106.
3. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJL. Comparative risk assessment collaborative group: selected major risk factors and global and regional burden of disease. Lancet 2002; 360:1347-1360.
4. Nissinen A, Bothig S, Granroth H, Lopez A. Hypertension in developing countries. World Health Stat Q 1988; 41:141-153.
5. Fuentes R, Ilmaniemi N, Laurikainen E, Tuomilehto J, Nissinen A. Hypertension in developing economies: a review of population-based studies carried out from 1980 to 1998. J Hypertens 2000; 18:521-529.
6. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense H, Joffres M, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003; 289:2363-2369.
7. World Health Organization Collaborating Center for Surveillance of Cardiovascular Diseases, division of cardiology, University of Ottawa. Global Cardiovascular InfoBase. Available at web site http://cvdinfobase.ic.gc.ca/ (accessed 14 November 2001).
8. Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat. World Population Prospects: The 2000 Revision and World Urbanization Prospects: The 2001 Revision. Available at web site http:///esa.un.org/unpp (accessed 28 January 2002).
9. Gordis L. Epidemiology. 2nd ed. Philadelphia: W.B. Saunders; 2000.
10. World Bank. World Development Report 1993: Investing in Health. New York: Oxford University Press for the World Bank.
11. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003; 290:199-206.
12. Joffres MR, Ghadirian P, Fodor JG, Petrasovits A, Chockalingam A, Hamet P. Awareness, treatment, and control of hypertension in Canada. Am J Hypertens 1997; 10:1097-1102.
13. Banegas JR, Rodriguez-Artalejo F, de la Cruz Troca JJ, Guallar-Castillon P, del Rey Calero J. Blood pressure in Spain: distribution, awareness, control, and benefits of a reduction in average pressure. Hypertension 1998; 32:998-1002.
14. De Henauw S, De Bacquer D, Fonteyne W, Stam M, Kornitzer M, De Backer G. Trends in the prevalence, detection, treatment and control of arterial hypertension in the Belgian adult population. J Hypertens 1998; 16:277-284.
15. Primatesta P, Brookes M, Poulter NR. Improved hypertension management and control: results from the health survey for England 1998. Hypertension 2001; 38:827-832.
16. Kastarinen MJ, Salomaa W, Vartiainen EA, Jousilahti PJ, Tuomilehto JO, Puska PM, Nissinen AM. Trends in blood pressure levels and control of hypertension in Finland from 1982 to 1997. J Hypertens 1998; 16:1379-1387.
17. Thamm M. Blood pressure in Germany: current status and trends. Gesundheitswesen 1999; 61: S90-S93.
18. Stergiou GS, Thomopoulou GC, Skeva, II, Mountokalakis TD. Prevalence, awareness, treatment, and control of hypertension in Greece: the Didima study. Am J Hypertens 1999; 12:959-965.
19. Giampaoli S, Palmieri L, Dima F. Socioeconomic aspects and cardiovascular risk factors: experience at the Cardiovascular Epidemiologic Observatory. Ital Heart J 2001; 2:294-302.
20. Stegmayr B, Harmsen P, Rajakangas A. Stroke around the Baltic Sea: incidence, case fatality and population risk factors in Denmark, Finland, Sweden and Lithuania. Cerebrovasc Dis 1996; 6:80-88.
21. Bennett SA, Magnus P. Trends in cardiovascular risk factors in Australia. Results from the National Heart Foundation's Risk Factor Prevalence Study, 1980-1989. Med J Aust 1994; 161:519-527.
22. National Cardiovascular Disease Database. Cardiovascular risk factors report. AIHW analysis of the NHF Risk Factor Prevalence Study. Available at web site http://www.aihw.gov.au/pls/cvd/cvd_risk.show_form (accessed 27 February 2002).
23. Baba S, Pan WH, Ueshima H, Ozawa H, Komachi Y, Stamler R, et al. Blood pressure levels, related factors, and hypertension control status of Japanese and Americans. J Hum Hypertens 1991; 5:317-332.
24. Rywik SL, Davis CE, Pajak A, Broda G, Folsom AR, Kawalec E, Williams OD. Poland and US collaborative study on cardiovascular epidemiology hypertension in the community: prevalence, awareness, treatment, and control of hypertension in the Pol-MONICA Project and the US Atherosclerosis Risk in Communities Study. Ann Epidemiol 1998; 8:3-13.
25. Malhotra P, Kumari S, Kumar R, Jain S, Sharma BK. Prevalence and determinants of hypertension in an un-industrialised rural population of North India. J Hum Hypertens 1999; 13:467-472.
26. Singh RB, Beegom R, Ghosh S, Niaz MA, Rastogi V, Rastogi SS, et al. Epidemiological study of hypertension and its determinants in an urban population of North India. J Hum Hypertens 1997; 11:679-685.
27. Singh RB, Sharma JP, Rastogi V, Niaz MA, Singh NK. Prevalence and determinants of hypertension in the Indian social class and heart survey. J Hum Hypertens 1997; 11:51-56.
28. Gupta R, Guptha S, Gupta VP, Prakash H. Prevalence and determinants of hypertension in the urban population of Jaipur in western India. J Hypertens 1995; 13:1193-1200.
29. Gupta R, Sharma AK. Prevalence of hypertension and subtypes in an Indian rural population: clinical and electrocardiographic correlates. J Hum Hypertens 1994; 8:823-829.
30. Freeman V, Fraser H, Forrester T, Wilks R, Cruickshank J, Rotimi C, Cooper R. A comparative study of hypertension prevalence, awareness, treatment and control rates in St Lucia, Jamaica and Barbados. J Hypertens 1996; 14:495-501.
31. Arroyo P, Fernandez V, Loria A, Kuri-Morales P, Orozco-Rivadeneyra S, Olaiz G, et al. Hypertension in urban Mexico: the 1992-93 national survey of chronic diseases. J Hum Hypertens 1999; 13:671-675.
32. Ramirez MO, Pino CT, Furiasse LV, Lee AJ, Fowkes FG. Paraguayan National Blood Pressure Study: prevalence of hypertension in the general population. J Hum Hypertens 1995; 9:891-897.
33. Sulbaran T, Silva E, Calmon G, Vegas A. Epidemiologic aspects of arterial hypertension in Maracaibo, Venezuela. J Hum Hypertens 2000; 14:S6-S9.
34. Ordunez-Garcia PO, Espinosa-Brito AD, Cooper RS, Kaufman JS, Nieto FJ. Hypertension in Cuba: evidence of a narrow black-white difference. J Hum Hypertens 1998; 12:111-116.
35. Ibrahim MM, Rizk H, Appel LJ, Aroussy W, Helmy S, Sharaf Y, et al. Hypertension prevalence, awareness, treatment, and control in Egypt. Results from the Egyptian National Hypertension Project (NHP). NHP Investigative Team. Hypertension 1995; 26:886-890.
36. Sarraf-Zadegan N, Boshtam M, Mostafavi S, Rafiei M. Prevalence of hypertension and associated risk factors in Isfahan, Islamic Republic of Iran. East Mediterr Health J 1999; 5:992-1001.
37. Sonmez HM, Basak O, Camci C, Baltaci R, Karazeybek HS, Yazgan F, et al. The epidemiology of elevated blood pressure as an estimate for hypertension in Aydin, Turkey. J Hum Hypertens 1999; 13:399-404.
38. Gu D, Reynolds K, Wu X, Chen J, Duan X, Muntner P, et al. Prevalence, awareness, treatment, and control of hypertension in China. Hypertension 2002; 40:920-927.
39. Kim JS, Jones DW, Kim SJ, Hong YP. Hypertension in Korea: a national survey. Am J Prev Med 1994; 10:200-204.
40. Cheepudomwit S, Chapman N, He J, Neal B, Suriyawongpaisal P, Whelton PK, Woodward M. Cardiovascular risk factor levels in urban and rural Thailand. Results from the International Collaborative Study of Cardiovascular Disease in ASIA. J Cardiovasc Risk (in press).
41. Cutter J, Tan BY, Chew SK. Levels of cardiovascular disease risk factors in Singapore following a national intervention programme. Bull WHO 2001; 79:907.
42. Janus ED. Epidemiology of cardiovascular risk factors in Hong Kong. Clin Exp Pharmacol Physiol 1997; 24:987-988.
43. Chen CH, Chuang JH, Kuo HS, Chang MS, Wang SP, Chou P. A population-based epidemiological study on cardiovascular risk factors in Kin-Chen, Kinmen. Int J Cardiol 1995; 48:75-88.
44. Dowse GK, Gareeboo H, Alberti KG, Zimmet P, Tuomilehto J, Purran A, et al. Changes in population cholesterol concentrations and other cardiovascular risk factor levels after five years of the non-communicable disease intervention programme in Mauritius. Mauritius Non-communicable Disease Study Group. BMJ 1995; 311:1255-1259.
45. Pan WH, Chang HY, Yeh WT, Hsiao SY, Hung YT. Prevalence, awareness, treatment and control of hypertension in Taiwan: results of Nutrition and Health Survey in Taiwan (NAHSIT) 1993-1996. J Hum Hypertens 2001; 15:793-798.
46. Steyn K, Gaziano TA, Bradshaw D, Laubscher R, Fourie J. South African Demographic and Health Coordinating Team. Hypertension in South African adults: results from the Demographic and Health Survey, 1998. J Hypertens 2001; 19:1717-1725.
47. Mbanya JC, Minkoulou EM, Salah JN, Balkau B. The prevalence of hypertension in rural and urban Cameroon. Int J Epidemiol 1998; 27:181-185.
48. Cooper R, Rotimi C, Ataman S, McGee D, Osotimehin B, Kadiri S, et al. The prevalence of hypertension in seven populations of west African origin. Am J Public Health 1997; 87:160-168.
49. Edwards R, Unwin N, Mugusi F, Whiting D, Rashid S, Kissima J, et al. Hypertension prevalence and care in an urban and rural area of Tanzania. J Hypertens 2000; 18:145-152.
50. Mufunda J, Scott LJ, Chifamba J, Matenga J, Sparks B, Cooper R, Sparks H. Correlates of blood pressure in an urban Zimbabwean population and comparison to other populations of African origin. J Hum Hypertens 2000; 14:65-73.
51. Astagneau P, Lang T, Delarocque E, Jeannee E, Salem G. Arterial hypertension in urban Africa: an epidemiological study on a representative sample of Dakar inhabitants in Senegal. J Hypertens 1992; 10:1095-1101.
52. Van der Sande M, Bailey R, Faal H, Banya W, Dolin P, Nyan O, et al. Nationwide prevalence study of hypertension and related non-communicable disease in The Gambia. Trop Med Int Health 1997; 2:1039-1048.
53. Reynolds K, Gu D, Muntner P, Wu X, Chen J, Huang G, et al. Geographic variations in the prevalence, awareness, treatment and control of hypertension in China. J Hypertens 2003; 7:1273-1281.
54. Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton P, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population: Data from the health examination surveys, 1960 to 1991. Hypertension 1995; 26:60-69.
55. Gasse C, Hense HW, Stieber J, Doring A, Liese AD, Keil U. Assessing hypertension management in the community: trends of prevalence, detection, treatment, and control of hypertension in the MONICA Project, Augsburg 1984-1995. J Hum Hypertens 2001; 15:27-36.
56. Moulopoulos SD, Adamopoulos PN, Diamantopoulos EI, Nanas SN, Anthopoulos LN, Iliadi-Alexandrou M. Coronary heart disease risk factors in a random sample of Athenian adults. The Athens Study. Am J Epidemiol 1987; 126:882-892.
57. Wu X, Duan X, Gu D, Hao J, Tao S, Fan D. Prevalence of hypertension and its trends in Chinese populations. Int J Cardiol 1995; 52:39-44.
58. Gupta R, Al-Odat NA, Gupta VP. Hypertension epidemiology in India: meta-analysis of 50-year prevalence rates and blood pressure trends. J Hum Hypertens 1996; 10:465-472.
59. Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton PK, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension 1995; 26:60-69.
60. Jones DW, Kim JS, Kim SJ, Hong YP. Hypertension awareness, treatment and control rates for an Asian population: results from a national survey in Korea. Ethn Health 1996; 1:269-273.
61. Colhoun HM, Dong W, Poulter NR. Blood pressure screening, management and control in England: results from the Health Survey for England 1994. J Hypertens 1998; 16:747-753.
62. Tao S, Wu X, Duan X, Fang W, Hao J, Fan D, et al. Hypertension prevalence and status of awareness, treatment and control in China. Chin Med J (Engl) 1995; 108:483-489.
63. Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560-2572.
64. Mulrow PJ. Hypertension. A worldwide epidemic. In: Izzo JL, Black HR (editors): Hypertension primer. 2nd ed. Dallas: American Heart Association; 1999, pp. 271-273.
65. He J, Muntner P, Chen J, Roccella EJ, Streiffer RH, Whelton PK. Factors associated with hypertension control in the general population of the United States. Arch Intern Med 2002; 162:1051-1058.
66. Khot UM, Khot MB, Bajzer CT, Sapp SK, Ohman EM, Brener SJ, et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA 2003; 290:898-904.
67. Greenland P, Knoll MD, Stamler J, Neaton JD, Dyer AR, Garside DB, Wilson PW. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA 2003; 290:891-897.
68. Whelton PK, He J, Appel LJ, Cutler JA, Havas S, Kotchen TA, et al. Primary prevention of hypertension clinical and public health advisory from the national high blood pressure education program. JAMA 2002; 288:1882-1888.